Status:
COMPLETED
Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hepatitis C, Chronic
Eligibility:
All Genders
18+ years
Brief Summary
The current gold standard for treatment of chronic hepatitis C (CHC) patients is with pegylated interferon plus ribavirin. Drug administration accuracy and ease of use will definitely determine treatm...
Detailed Description
Enrollment of patients will occur in a sequential order of treatment initiation.
Eligibility Criteria
Inclusion
- Adult patients with hepatitis C
Exclusion
- According to the products' labeling.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
1995 Patients enrolled
Trial Details
Trial ID
NCT00727259
Start Date
October 1 2004
End Date
April 1 2008
Last Update
April 29 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.